FUB-144

FUB-144 (also known as FUB-UR-144) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1] It is an analogue of UR-144 and XLR-11 where the pentyl chain has been replaced with fluorobenzyl.

FUB-144
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC23H24FNO
Molar mass349.449 g·mol−1
3D model (JSmol)

In the United States, FUB-144 became a Schedule I Controlled Substance in 2019.[2]

Sweden's public health agency suggested classifying FUB-144 as hazardous substance on March 24, 2015.[3]

See also

References

  1. "FUB-144". Southern Association of Forensic Scientists. Archived from the original on 27 September 2015. Retrieved 23 July 2015.
  2. "Schedules of Controlled Substances: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 into Schedule I". Federal Register.
  3. "Fler ämnen föreslås bli klassade som narkotika eller hälsofarlig vara". Folkhälsomyndigheten. Retrieved 23 July 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.